GlassScriptPhysician profile
Matthew C Dorn
NPI 1649477209
$13,380.05
in general payments reported to CMS, 2019-2025
21 companies · $1,619 in 2025
The $1,619 reported for 2025 was more than what 79% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $209 · 2021: $26.15 · 2022: $39.48 · 2023: $924 · 2024: $10K · 2025: $1,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $7,819 · Travel and Lodging: $3,154 · Food and Beverage: $1,885 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $7,819.05 |
| Travel and Lodging | $3,154.09 |
| Food and Beverage | $1,884.60 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,806.97 | 2024-2025 | |
| Stryker Corporation | $848.37 | 2023 | 1688 |
| Pacira Pharmaceuticals Incorporated | $152.88 | 2020 | |
| Portola Pharmaceuticals, LLC | $125.94 | 2019-2020 | |
| Fujifilm Healthcare Americas Corporation | $101.17 | 2019 | |
| Davol INC. | $37.54 | 2024 | Phasix Mesh |
| Braintree Laboratories, INC. | $34.07 | 2023 | Sutab |
| Shire North American Group INC | $31.72 | 2019 | |
| W. L. Gore & Associates, INC. | $27.71 | 2024 | Gore Synecor Biomaterial |
| Abbvie INC. | $25.00 | 2022 | |
| Baxter Healthcare | $24.70 | 2023 | Floseal |
| Boston Scientific Corporation | $19.10 | 2019 | |
| Medtronic, INC. | $18.52 | 2024 | Progrip |
| Ethicon US, LLC | $17.63 | 2025 | Vistaseal |
| Conmed Corporation | $17.49 | 2024 | Airseal |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $17.22 | 2023 | Localizer |
| Medtronic Vascular, INC. | $17.13 | 2020 | |
| Angiodynamics, INC. | $16.26 | 2024 | Smart Port Ct |
| Takeda Pharmaceuticals U.S.A., INC. | $16.11 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $14.48 | 2022 | |
| Endogastric Solutions, INC | $10.04 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Dorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.